Clinical applications of liquid biopsies for early lung cancer detection.
Hao Zheng(Novogene Bioinformatics Institute), Changxuan You(Southern Medical University), Xinyu Wu(New York University), Jie Yin(Hebei Medical University), Shuang Wang(National Institutes of Health Clinical Center), Zhi Li(Beijing Normal University)
PubMed
January 1, 2019
Cited by 25
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
|Annals of Oncology|2015|467
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
|Cell|2024|272